Dr Habeebullah Life Sciences Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported revenue was INR 0.406 million compared to INR 0.364 million a year ago. Net loss was INR 0.237 million compared to INR 3.03 million a year ago. Basic loss per share from continuing operations was INR 0.02 compared to INR 0.19 a year ago. Diluted loss per share from continuing operations was INR 0.02 compared to INR 0.19 a year ago. For the six months, revenue was INR 0.801 million compared to INR 0.848 million a year ago. Net loss was INR 0.679 million compared to INR 5.74 million a year ago. Basic loss per share from continuing operations was INR 0.05 compared to INR 0.38 a year ago. Diluted loss per share from continuing operations was INR 0.05 compared to INR 0.38 a year ago.